Cardiovascular and CKD-Related Healthcare Costs for Patients with Type 2 Diabetes and CKD

被引:0
|
作者
Singh, Rakesh [1 ]
Song, Jinlin [2 ]
Faust, Elizabeth [3 ]
Du, Yuxian [1 ]
Kong, Sheldon X. [1 ]
Betts, Keith A. [2 ]
机构
[1] Bayer Corp, Whippany, NJ USA
[2] Anal Grp Inc, Los Angeles, CA USA
[3] Anal Grp Inc, New York, NY USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PO0776
引用
收藏
页码:272 / 272
页数:1
相关论文
共 50 条
  • [21] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Singhal, Rohit
    Hechanova, Lisa Aimee
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 183 - 189
  • [22] Characteristics, Cardiovascular Comorbidity and Medicines Management in Patients with Type 2 Diabetes and CKD: Results of the IRIDIEM Study
    Stevens, P. E.
    Schernthaner, G.
    Raptis, S.
    Wanner, C.
    Scherhag, A.
    Lameire, N.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2010, 33 (02): : 119 - 128
  • [23] Hypoglycemia in People with Type 2 Diabetes and CKD
    Ahmad, Iram
    Zelnick, Leila R.
    Batacchi, Zona
    Robinson, Nicole
    Dighe, Ashveena
    Manski-Nankervis, Jo-Anne E.
    Furler, John
    O'Neal, David N.
    Little, Randie
    Trence, Dace
    Hirsch, Irl B.
    Bansal, Nisha
    de Boer, Ian H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (06): : 844 - 853
  • [24] Cardiovascular Events with Finerenone in CKD and Diabetes
    Kao, Pei-Heng
    Hsu, Li-Chuan
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (16):
  • [25] Trends in management of CKD-related anemia in the Veterans Health Administration (VHA).
    Seliger, S. L.
    Hsu, V. D.
    Walker, L.
    Fink, J. C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A73 - A73
  • [26] THE EFFECT OF DAPRODUSTAT ON INTRAVENOUS IRON USE IN PATIENTS WITH CKD-RELATED ANAEMIA ON DIALYSIS IN THE ASCEND TRIALS
    Pergola, Pablo
    Ganz, Tomas
    Nemeth, Elizabeta
    Bailey, Christine K.
    Bhatt, Purav
    Meadowcroft, Amy
    Shannon, Jennifer B.
    Del Vecchio, Lucia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I646 - I647
  • [27] Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study
    Chase, Herbert S.
    Hirsch, Jamie S.
    Mohan, Sumit
    Rao, Maya K.
    Radhakrishnan, Jai
    BMC NEPHROLOGY, 2014, 15
  • [28] Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study
    Herbert S Chase
    Jamie S Hirsch
    Sumit Mohan
    Maya K Rao
    Jai Radhakrishnan
    BMC Nephrology, 15
  • [29] Cardiovascular Disease in Patients With CKD
    不详
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : S60 - S78
  • [30] Measured GFR Does Not Outperform Estimated GFR in Predicting CKD-related Complications
    Hsu, Chi-yuan
    Propert, Kathleen
    Xie, Dawei
    Hamm, Lee
    He, Jiang
    Miller, Edgar
    Ojo, Akinlolu
    Shlipak, Michael
    Teal, Valerie
    Townsend, Raymond
    Weir, Matthew
    Wilson, Jillian
    Feldman, Harold
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (10): : 1931 - 1937